Biobanks are an important compound of personalized medicine and are central when accelerating the discovery and development of new drugs. Besides, biobanks play a key role in identification of new biomarkers.
This webinar will present three central institutions in the Danish research landscape within personalized medicine. All presentations will focus on concrete services and opportunities for collaboration and demonstrate how industry partners can benefit from collaborating with the Danish research community.
First, the Danish National Biobank, which main purpose is to give scientists from Denmark and abroad easy access to information from more than 25 million biological samples.
Second, the Nationwide Bio- and Genome Bank Denmark, which is a virtual national biobank with samples within e.g. cancer, rheumatology, diabetes, blood and Covid-19 that are available to national and international research projects.
Third, the Danish National Genome Center, which supports further development of more effective treatments, targeted the individual patient by the use of genome data and new technologies in Denmark.